Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
18.3M
-
Shares change
-
-3.91M
-
Total reported value, excl. options
-
$88.2M
-
Value change
-
-$23.8M
-
Put/Call ratio
-
4.05
-
Number of buys
-
24
-
Number of sells
-
-51
-
Price
-
$4.82
Significant Holders of Arrowhead Pharma Inc - COM (ARWR) as of Q1 2016
105 filings reported holding ARWR - Arrowhead Pharma Inc - COM as of Q1 2016.
Arrowhead Pharma Inc - COM (ARWR) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.3M shares
.
Largest 10 shareholders include OppenheimerFunds, Inc. (3M shares), VANGUARD GROUP INC (2.38M shares), BlackRock Fund Advisors (2.3M shares), QVT Financial LP (2.05M shares), BlackRock Institutional Trust Company, N.A. (1.55M shares), JPMORGAN CHASE & CO (1.52M shares), AMERIPRISE FINANCIAL INC (1.01M shares), NORTHERN TRUST CORP (607K shares), First Light Asset Management, LLC (492K shares), and GEODE CAPITAL MANAGEMENT, LLC (408K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.